Cara Therapeutics

June 3rd is National Itch Day! At Cara Therapeutics, we understand that #pruritus is more than just an #itch for the millions of people who suffer from the burdensome condition. Chronic pruritus can be all-consuming and have a significant impact on overall well-being. To learn how we’re working to transform the way pruritus is treated, visit www.CaraTherapeutics.com. #NationalItchDay 

Today we honor the women and men who lost their lives while serving our nation. We will always remember their sacrifices for our freedom.

This Women’s Health Month, we’re shining a light on notalgia paresthetica (NP), a sensory neuropathy that more commonly impacts women than men. 💡NP affects the upper back. 💡A hallmark feature of NP is chronic pruritus. 💡Currently, there are no FDA-approved therapies for NP. To learn more about #pruritus in NP, visit: https://lnkd.in/e9Qcwwy9 #WomensHealthMonth #NotalgiaParesthetica #itch

Cara Therapeutics Reports First Quarter 2024 Financial Results https://lnkd.in/ehp6ZXKw

Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024 https://lnkd.in/eGKrm2U8

We are evaluating our investigational therapy, oral difelikefalin, for the treatment of moderate-to-severe #pruritus in patients with notalgia paresthetica (NP). If you’re not familiar with NP, it’s a sensory neuropathy characterized by chronic pruritus (#itch). Currently, there are no FDA-approved therapies for NP. To learn more about #NotalgiaParesthetica, check out the replay of our “Meet the NP Experts” webcast available on the “Events & Presentations” page in the Investors section of our website, www.CaraTherapeutics.com.

Reminder: Our CEO Chris Posner is presenting at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9 at 8:40 a.m. EDT. A webcast of the presentation will be available under "Events & Presentations" in the Investors section of our website at www.CaraTherapeutics.com. #NotalgiaParesthetica #pruritus

Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference https://lnkd.in/eCp5eDR9

Don’t miss our virtual key opinion leader event, Meet the NP Experts, on Wednesday, March 27 at 10 a.m. EDT! Tune in to hear an insightful discussion about notalgia paresthetica (NP) with leaders in the field of neuropathic #pruritus and learn about the potential of our investigational therapy, oral difelikefalin, in this common, underdiagnosed neuropathy for which there are no FDA-approved therapies. If you haven’t registered yet, there’s still time to do so here: https://lnkd.in/eCFwC8cA   #NotalgiaParesthetica #dermatology #itch

Mark your calendar for “Meet the NP Experts” on Wednesday, March 27 at 10 a.m. EDT. During a live panel discussion, Brian S. Kim, Gil Yosipovitch and Melinda Gooderham will discuss the epidemiology, diagnosis, treatment landscape, and significant unmet medical need in notalgia paresthetica (NP). The virtual key opinion leader event will also highlight the potential of an investigational therapy, oral difelikefalin, in this underserved neuropathy.   Learn more and register here: https://lnkd.in/eCFwC8cA   #NotalgiaParesthetica #NeuropathicPruritus #pruritus #dermatology